| The Company has established
a Scientific Advisory Board comprised of individuals with broad expertise
in relevant areas. The advisory board meets at the Company's request
to review and evaluate the Company's scientific progress and plans
and to identify and evaluate scientific developments that may be of
commercial interest to the Company. The members of the Scientific
Advisory Board are:
Michael E. DeBakey, M.D., is Chancellor Emeritus,
Distinguished Service Professor & Olga Keith Wiess Professor
of Surgery, Baylor College of Medicine. Dr. DeBakey's surgical career
has earned him world renown as a surgeon, innovator, teacher and
medical statesman. While still a medical student, he devised a pump
that years later became one of the essential components of the heart-lung
machine that made open-heart surgery possible. To date, he has developed
more than 50 surgical instruments and is best known for his innovations
in treating cardiovascular diseases. He has authored and published
more than 1,000 medical articles, chapters, and books. Dr. DeBakey
has also served as Chairman of the President's Commission on Heart
Disease, Cancer, and Stroke during the Administration of President
Lyndon Johnson and as a member on the National Advisory Heart and
Lung Council of the National Institutes of Health. Dr. DeBakey also
holds memberships and fellowships in numerous medical surgical societies
throughout the world and has received honors from many heads of
state, including the United States Medal of Freedom, the highest
honor the President can bestow on a civilian.
George P. Noon, M.D., is a Professor of Surgery and
Chief, Division of Transplant & Assist Devices, Baylor College
of Medicine; Executive Director, Multi-Organ Transplant Center,
The Methodist Hospital, Houston, Texas. He has been involved in
artificial heart research since 1966 and implanted an artificial
heart in a Russian patient in 1967 as a Delegate of the United States-U.S.S.R.
Artificial Heart Program.
O. H. Frazier, M.D., is the Director, Cardiovascular
Surgical Research, Co-Director, Cullen Cardiovascular Research Laboratories,
and Chief, Cardiopulmonary Transplantation, Texas Heart Institute;
Chief, Transplant Service, St. Luke's Episcopal Hospital. Dr. Frazier
is a distinguished surgeon, scientist, and academician who has applied
his vast experience to the research and development of new cardiovascular
surgical techniques, including the development of artificial heart
and circulatory assist devices. His primary clinical interests are
cardiopulmonary transplantation and heart assist devices, including
total artificial hearts.
Nadim M. Zacca, M.D., is a Clinical Associate Professor
of Medicine, Baylor College of Medicine. He has been involved in
research related to cardiac catheterization since 1979 and has been
the Associate Director and Director of the Catheterization Laboratory
at Veterans Administration Hospital, Houston, TX. Dr. Zacca, while
at BCM in the mid 1980's, was the core clinical contributor for
the development of the original Rotablator®, now sold by Boston
Scientific.
|
